Leukemia Stem Cells more like Embryonic Stem cells than Adult stem cells
Topic: Regenerative Medicine
Author: Cell Press
Published: 2009/02/05
Contents: Summary - Introduction - Main Item - Related Topics
Synopsis: Leukemia stem cells have more in common with embryonic stem cells than adult stem cells.
Introduction
Research using a mouse model of human leukemia has provided critical insight into the genetic factors related to the generation and maintenance of Myeloid leukemia stem cells. The study, published by Cell Press in the February 6th issue of the journal Cell Stem Cell, is likely to have a profound impact on the future design of therapeutic approaches targeted against cancer stem cells.Main Item
Research using a mouse model of human leukemia has provided critical insight into the genetic factors related to the generation and maintenance of Myeloid leukemia stem cells. The study, published by Cell Press in the February 6th issue of the journal Cell Stem Cell, is likely to have a profound impact on the future design of therapeutic approaches targeted against cancer stem cells.
Leukemia stem cells (LSCs) were initially described as rare cells that share characteristics with normal hematopoietic stem cells (HSCs). HSCs are a type of partially committed adult stem cells that can give rise to multiple types of blood cells. However, recent research has demonstrated that LSCs can represent a significant fraction of leukemic cells and exhibit characteristics associated with more mature, differentiated Myeloid cells rather than the more versatile HSCs.
"Since LSCs may be more numerous and mature than originally proposed, the nature and generality of the hierarchical organization of malignancies has recently been questioned," says senior study author Dr. Michael L. Cleary, from the Department of Pathology at Stanford University. Dr. Cleary and colleagues used a mouse model of human AML to investigate the genes that maintain LSC frequencies and leukemia cell hierarchies.
The researchers found that LSCs are maintained in a self-renewing state by subversion of a transcriptional program that shares features with pluripotent embryonic stem cells (ESCs). This transcriptional program is transiently expressed in normal Myeloid precursor cells rather than HSCs or fully mature white blood cells. The authors go on to reveal a link between activation of genes associated with ESCs at an inappropriate stage of white blood cell development, the number of LSCs, and a poor prognosis in leukemia.
"Importantly, the shared transcriptional features of LSCs, ESCs, normal mid-Myeloid lineage cells, and a diverse set of poor-prognosis human malignancies support the broader conclusion that cancer stem cells may be aberrantly self-renewing downstream progenitor cells," explains lead study author Dr. Tim Somervaille.
The study also highlights the potential of therapeutic strategies aimed at genes and pathways that are of greater importance to the function of LSCs than HSCs. "These findings may have a substantial clinical impact, as normal HSCs are necessary for regeneration of hematopoiesis following chemotherapy," offers Dr. Cleary.
Reference: The researchers include Tim C.P. Somervaille, Stanford University, Stanford, CA, Cancer Research UK Leukaemia Biology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK; Christina J. Matheny, Stanford University, Stanford, CA; Gary J. Spencer, Cancer Research UK Leukaemia Biology Group, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK; Masayuki Iwasaki, Stanford University, Stanford, CA; John L. Rinn, Stanford University, Stanford, CA; Daniela M. Witten, Stanford University, Stanford, CA; Howard Y. Chang, Stanford University, Stanford, CA; Sheila A. Shurtleff, St. Jude Children's Research Hospital, Memphis, TN; James R. Downing, St. Jude Children's Research Hospital, Memphis, TN; and Michael L. Cleary, Stanford University, Stanford, CA.
Explore Related Topics
1 - New Ethical Framework Introduced for Stem Cell-Based Embryo Research - A groundbreaking code of practice has been introduced for the use of stem cell-based embryo models in research.
2 - Making Stem Cells Behave Like Human Embryos - Human pluripotent stem cells in a lab can initiate a process resembling the gastrulation phase - where cells begin differentiating into new cell types - much earlier than occurs in mother nature.
3 - Organoids: Fitting a Mini Brain with a Tiny Cap - A tiny EEG electrode cap was created to measure activity in an organoid brain model the size of a pen dot to lead to a better understanding of neural disorders and how chemicals affect the brain.
4 - Mouse Embryo Created from Stem Cells: No Sperm, Egg, Uterus Needed - Solely from stem cells, without egg, sperm or womb, synthetic mouse embryo models were created.
5 - Progress on Stem Cell Therapy to Restore Sight - A multi-institutional effort is taking steps to develop an effective technique to regenerate photoreceptors cells and restore sight in people with vision disorders.
Page Information, Citing and Disclaimer
Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.
Cite This Page (APA): Cell Press. (2009, February 5). Leukemia Stem Cells more like Embryonic Stem cells than Adult stem cells. Disabled World. Retrieved October 10, 2024 from www.disabled-world.com/news/research/stemcells/leukemia-stem-cells.php
Permalink: <a href="https://www.disabled-world.com/news/research/stemcells/leukemia-stem-cells.php">Leukemia Stem Cells more like Embryonic Stem cells than Adult stem cells</a>: Leukemia stem cells have more in common with embryonic stem cells than adult stem cells.
Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.